Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1576-82. doi: 10.1007/s00259-007-0483-5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Esophageal Neoplasms / diagnostic imaging*
  • Esophageal Neoplasms / therapy*
  • Fluorodeoxyglucose F18*
  • Humans
  • Positron-Emission Tomography / methods
  • Prognosis
  • Radiopharmaceuticals
  • Radiotherapy / methods*
  • Rectal Neoplasms / diagnostic imaging*
  • Rectal Neoplasms / radiotherapy
  • Rectal Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18